Observational Study of Drug-Induced Lung Injury Caused by Abemaciclib

Observational Study of Drug-Induced Lung Injury Caused by Abemaciclib - Observational Study of Drug-Induced Lung Injury Caused by Abemaciclib

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038806

Enrollment

300

Registered

2019-12-10

Start date

2019-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Women from whom consent to participate in the Observational Study of Abemaciclib for Chemotherapy-Treated Metastatic Breast Cancer, which is currently being conducted by the CSPOR-BC, is obtained 2) Women from whom written consent to participate in this ancillary study is obtained

Exclusion criteria

Exclusion criteria: 1) Women who are judged by their physicians in charge to be ineligible for any reason.

Design outcomes

Primary

Measure	Time frame
Incidence of drug-induced lung injury due to abemaciclib	—

Countries

Japan

Contacts

Public ContactComprehensive Support Project for Oncological Rese CSPOR-BC

Comprehensive Support Project for Oncological Research of Breast Cancer Office

office-bc@cspor-bc.or.jp04-7135-5609

Outcome results